307
Views
1
CrossRef citations to date
0
Altmetric
Research Papers

Savoring as an intervention for cannabis use: acceptability, feasibility, and preliminary results

ORCID Icon & ORCID Icon
Pages 296-305 | Received 31 May 2022, Accepted 16 Dec 2022, Published online: 30 Dec 2022

References

  • Abrams DI, Vizoso HP, Shade SB, Jay C, Kelly ME, Benowitz NL. 2007. Vaporization as a smokeless cannabis delivery system: a pilot study. Clin Pharmacol Ther. 82(5):572–578.
  • Andreae MH, Carter GM, Shaparin N, Suslov K, Ellis RJ, Ware MA, Abrams DI, Prasad H, Wilsey B, Indyk D, et al. 2015. Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient data. J Pain. 16(12):1221–1232.
  • Aviram J, Samuelly-Leichtag G. 2017. Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials. Pain Phys. 20(6):E755–E796.
  • Babor TF, Carroll K, Christiansen K, Donaldson J, Herrell J, Kadden R, Litt M, McRee B, Miller M, Roffman R, et al. 2004. Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol. 72(3):455–466.
  • Barrington J, Weaver A, Brebner K. 2019. Exploring mindfulness in relation to alcohol and cannabis use among first year university students. Coll Stud J. 53(2):163–175.
  • Bonn-Miller MO, Boden MT, Bucossi MM, Babson KA. 2014. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am J Drug Alcohol Abuse. 40(1):23–30.
  • Browne RH. 1995. On the use of a pilot sample for sample size determination. Stat Med. 14(17):1933–1940.
  • Bryant FB. 2003. Savoring Beliefs Inventory (SBI): a scale for measuring beliefs about savouring. J Ment Health. 12(2):175–196.
  • Bryant FB, Smart CM, King SP. 2005. Using the past to enhance the present: boosting happiness through positive reminiscence. J Happiness Stud. 6(3):227–260.
  • Bryant FB, Veroff J. 2007. Savoring: a new model of positive experience. In: Bryant FB, Veroff J, editors. Savoring: a new model of positive experience. Lawrence Erlbaum Associates. New York (NY): Psychology Press; p. 198.
  • Chen J, Zhou L. 2017. Savoring as a moderator between positive life events and hopelessness depression. Soc Behav Pers. 45(8):1337–1344.
  • Cheng H-F, Chen H-C. 2019. What drug offenders learn in the savoring group program. Chin J Guid Couns. 55:161–195.
  • Chiu HT, Yee LTS, Kwan JLY, Cheung RYM, Hou WK. 2020. Interactive association between negative emotion regulation and savoring is linked to anxiety symptoms among college students. J Am Coll Health. 68(5):494–501.
  • Copeland J, Clement N, Swift W. 2014. Cannabis use, harms and the management of cannabis use disorder. Neuropsychiatry. 4(1):55–63.
  • Dakwar E, Levin FR. 2013. Individual mindfulness-based psychotherapy for cannabis or cocaine dependence: a pilot feasibility trial. Am J Addict. 22(6):521–526.
  • Davis ML, Powers MB, Handelsman P, Medina JL, Zvolensky M, Smits JAJ. 2015. Behavioral therapies for treatment-seeking cannabis users: a meta-analysis of randomized controlled trials. Eval Health Prof. 38(1):94–114.
  • de Dios MA, Herman DS, Britton WB, Hagerty CE, Anderson BJ, Stein MD. 2012. Motivational and mindfulness intervention for young adult female marijuana users. J Subst Abuse Treat. 42(1):56–64.
  • Earleywine M, Barnwell SS. 2007. Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduct J. 4(11):1–4.
  • Earleywine M, Ueno LF, Mian MN, Altman BR. 2021. Cannabis-induced oceanic boundlessness. J Psychopharmacol. 35(7):841–847.
  • Fischer B, Russell C, Sabioni P, van den Brink W, Le Foll B, Hall W, Rehm J, Room R. 2017. Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations. Am J Public Health. 107(8):e1–e12.
  • Ford J, Klibert JJ, Tarantino N, Lamis DA. 2017. Savouring and self-compassion as protective factors for depression. Stress Health. 33(2):119–128.
  • Garland EL, Hanley AW, Kline A, Cooperman NA. 2019. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: ecological momentary assessments from a stage 1 randomized controlled trial. Drug Alcohol Depend. 203:61–65.
  • Garland EL, Howard MO. 2018. Mindfulness-based treatment of addiction: current state of the field and envisioning the next wave of research. Addict Sci Clin Pract. 13(1):1–14.
  • Garland EL, Roberts-Lewis A, Tronnier CD, Graves R, Kelley K. 2016. Mindfulness-Oriented Recovery Enhancement versus CBT for co-occurring substance dependence, traumatic stress, and psychiatric disorders: proximal outcomes from a pragmatic randomized trial. Behav Res Ther. 77:7–16.
  • Gates PJ, Sabioni P, Copeland J, Le Foll B, Gowing L. 2016. Psychosocial interventions for cannabis use disorder. Cochrane Database Syst Rev. 2016(5):CD005336.
  • Gieringer D, St. Laurent J, Goodrich S. 2004. Cannabis vaporizer combines efficient delivery of THC with effective suppression of pyrolytic compounds. J Cannabis Therap. 4(1):7–27.
  • Grant S, Colaiaco B, Motala A, Shanman R, Booth M, Sorbero M, Hempel S. 2017. Mindfulness-based relapse prevention for substance use disorders: a systematic review and meta-analysis. J Addict Med. 11(5):386–396.
  • Grant JD, Scherrer JF, Lyons MJ, Tsuang M, True WR, Bucholz KK. 2005. Subjective reactions to cocaine and marijuana are associated with abuse and dependence. Addict Behav. 30(8):1574–1586.
  • Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL. 2014. A survey of synthetic cannabinoid consumption by current cannabis users. Subst Abus. 35(2):184–189.
  • Herman PM, Anderson ML, Sherman KJ, Balderson BH, Turner JA, Cherkin DC. 2017. Cost-effectiveness of mindfulness-based stress reduction versus cognitive behavioral therapy or usual care among adults with chronic low back pain. Spine. 42(20):1511–1520.
  • Hoeppner BB, Schick MR, Carlon H, Hoeppner SS. 2019. Do self-administered positive psychology exercises work in persons in recovery from problematic substance use? An online randomized survey. J Subst Abuse Treat. 99:16–23.
  • Hunt N, Ashton M, Lenton S, Mitcheson L, Nelles B, Stimson G. 2003. A review of the evidence-base for harm reduction approaches to drug use. In: Forward thinking on drugs: a release initiative. London: Forward Thinking On Drugs-A Release Initiative.
  • Hurley DB, Kwon P. 2012. Results of a study to increase savoring the moment: differential impact on positive and negative outcomes. J Happiness Stud. 13(4):579–588.
  • Kadden RM, Litt MD, Kabela-Cormier E, Petry NM. 2007. Abstinence rates following behavioral treatments for marijuana dependence. Addict Behav. 32(6):1220–1236.
  • Kalant H. 2004. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry. 28(5):849–863.
  • Karyadi KA, VanderVeen JD, Cyders MA. 2014. A meta-analysis of the relationship between trait mindfulness and substance use behaviors. Drug Alcohol Depend. 143(1):1–10.
  • Krentzman AR. 2013. Review of the application of positive psychology to substance use, addiction, and recovery research. Psychol Addict Behav. 27(1):151–165.
  • Lancaster GA, Dodd S, Williamson PR. 2004. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 10(2):307–312.
  • Lau N, Sales P, Averill S, Murphy F, Sato SO, Murphy S. 2015. Responsible and controlled use: older cannabis users and harm reduction. Int J Drug Policy. 26(8):709–718.
  • Lavender JM, Looby A, Earleywine M. 2008. A brief cannabis-associated problems questionnaire with less potential for bias. Hum Psychopharmacol. 23(6):487–493.
  • Li W, Howard MO, Garland EL, McGovern P, Lazar M. 2017. Mindfulness treatment for substance misuse: a systematic review and meta-analysis. J Subst Abuse Treat. 75:62–96.
  • Lile JA, Turner BW, Cox DH, Bonn-Miller MO, Katz NR, Shellenberg TP, Stoops WW, Strickland JC. 2022. Cannabis use disorder treatment preferences: a pilot survey in current users of cannabis. J Addict Med. [accessed 2022 Apr 26]. https://journals.lww.com/journaladdictionmedicine/Fulltext/9900/Cannabis_Use_Disorder_Treatment_Preferences__A.63.aspx.
  • Luba RR, Earleywine M, Melse B, Gordis EB. 2020. Savoring Moderates the Link between Marijuana Use and Marijuana Problems. Subst Use Misuse. 55(2):291–295.
  • Malivoire BL, Marcotte-Beaumier G, Sumantry D, Koerner N. 2022. Correlates of dampening and savoring in generalized anxiety disorder. J Cogn Ther. 15:414–433.
  • Malouff JM, Rooke SE, Copeland J. 2014. Experiences of Marijuana-vaporizer users. Subst Abus. 35(2):127–128.
  • Mellis AM, Bickel WK. 2020. Mechanical Turk data collection in addiction research: utility, concerns and best practices. Addiction. 115(10):1960–1968.
  • Mian MN, Altman BR, Ueno LF, Earleywine M. 2021. Confirming savoring’s link to fewer cannabis problems. J Psychoactive Drugs. 53(3):201–206.
  • Osborne JW. 2013. Best practices in data cleaning. Thousand Oaks, CA: Sage.
  • Paltun SC, Altunsoy N, Özdemir SD, Okay IT. 2017. Does trait mindfulness level affect quitting cannabis use? A six week follow-up study. Arch Clin Psychiatry. 44(6):139–144.
  • Pearson MR. 2019. A meta-analytic investigation of the associations between cannabis use and cannabis-related negative consequences. Psychol Addict Behav. 33(3):190–196.
  • Priester MA, Browne T, Iachini A, Clone S, DeHart D, Seay KD. 2016. Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J Subst Abuse Treat. 61:47–59.
  • Riggs NR, Conner BT, Parnes JE, Prince MA, Shillington AM, George MW. 2018. Marijuana eCHECKUPTO GO: effects of a personalized feedback plus protective behavioral strategies intervention for heavy marijuana-using college students. Drug Alcohol Depend. 190:13–19.
  • Rooke SE, Norberg MM, Copeland J. 2011. Successful and unsuccessful cannabis quitters: comparing group characteristics and quitting strategies. Subst Abuse Treat Prev Policy. 6(1):30–39.
  • Russo E, Guy GW. 2006. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses. 66(2):234–246.
  • Schafer J, Brown SA. 1991. Marijuana and cocaine effect expectancies and drug use patterns. J Consult Clin Psychol. 59(4):558–565.
  • Sherman BJ, McRae-Clark AL. 2016. Treatment of cannabis use disorder: current science and future outlook. Pharmacotherapy. 36(5):511–535.
  • Shrout PE, Stadler G, Lane SP, Joy McClure M, Jackson GL, Clavél FD, Iida M, Gleason MEJ, Xu JH, Bolger N. 2018. Initial elevation bias in subjective reports. Proc Natl Acad Sci U S A. 115(1):E15–E23.
  • Smith JL, Hanni AA. 2019. Effects of a savoring intervention on resilience and well-being of older adults. J Appl Gerontol. 38(1):137–152.
  • Smith JL, Hollinger-Smith L. 2015. Savoring, resilience, and psychological well-being in older adults. Aging Ment Health. 19(3):192–200.
  • Stephens RS, Roffman RA, Curtin L. 2000. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol. 68(5):898–908.
  • Stockings E, Zagic D, Campbell G, Weier M, Hall WD, Nielsen S, Herkes GK, Farrell M, Degenhardt L. 2018. Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence. J Neurol Neurosurg Psychiatry. 89(7):741–753.
  • Strickland JC, Stoops WW. 2019. The use of crowdsourcing in addiction science research: Amazon Mechanical Turk. Exp Clin Psychopharmacol. 27(1):1–18.
  • Subritzky T. 2018. Beyond deficit and harm reduction: incorporating the spectrum of wellness as an interpretive framework for cannabis consumption. Int J Drug Policy. 60:18–23.
  • Substance Abuse and Mental Health Services Administration. 2020. Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health. HHS Publication No. PEP20-07-01-001, NSDUH Series H-55. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.
  • Suraev AS, Marshall NS, Vandrey R, McCartney D, Benson MJ, McGregor IS, Grunstein RR, Hoyos CM. 2020. Cannabinoid therapies in the management of sleep disorders: a systematic review of preclinical and clinical studies. Sleep Med Rev. 53:101339.
  • Swift W, Copeland J, Lenton S. 2000. Cannabis and harm reduction. Drug and Alcohol Review. 19(1):101–112.
  • Sytine AI, Britt TW, Pury CL, Rosopa PJ. 2018. Savouring as a moderator of the combat exposure–mental health symptoms relationship. Stress Health. 34(4):582–588.
  • Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, Robson R, Thabane M, Giangregorio L, Goldsmith CH. 2010. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 10(1):1–10.
  • Van Dam NT, Earleywine M. 2010. Pulmonary function in cannabis users: support for a clinical trial of the vaporizer. Int J Drug Policy. 21(6):511–513.
  • Volkow ND, Baler RD, Compton WM, Weiss SRB. 2014. Adverse health effects of marijuana use. N Engl J Med. 370(23):2219–2227.
  • Wang BA, Poole LZ, Balderrama-Durbin CM. 2022. Effects and mechanisms of a savoring-based single session intervention for partnered individuals. Int J Appl Posit Psychol. 2022:1–24.
  • Watson D, Clark L. 1994. The Panas-X. Manual for the positive and negative affect schedule-expanded form. Iowa City, Iowa: The University of Iowa.
  • Zhang Y, Xue J, Huang Y. 2020. A meta-analysis: internet mindfulness-based interventions for stress management in the general population. Medicine. 99(28):e20493.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.